Lifestance Health Group, Inc. (LFST) Stock Price & Analysis
Lifestance Health Group, Inc. (LFST) rose 0.83% to USD 10.9 as of July 25, 2026 at 03:07 UTC, according to Nexqual real-time market data.
LFST last closed at USD 10.81; the session ranged USD 10.87–11.29 on volume of 1,519,393 shares. Market capitalization is $4.16B, with a 52-week range of USD 3.74–11.76 (NMS). Source: Nexqual, July 25, 2026 at 03:07 UTC.
Key Statistics (as of July 25, 2026 at 03:07 UTC)
| Price | USD 10.9 |
|---|---|
| Change | ▲ 0.83% (up) |
| Previous Close | USD 10.81 |
| Open | USD 11.13 |
| Day Range | USD 10.87 – 11.29 |
| 52-Week Range | USD 3.74 – 11.76 |
| Volume | 1,519,393 shares |
| Market Cap | $4.16B |
| Exchange | NMS |
Technical Analysis (LFST)
Nexqual's technical model rates LFST "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:07 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 61.81 (neutral) |
| vs SMA50 | Above (USD 9.25) |
| MACD | 0.52 (positive) |
Analyst Ratings (LFST)
Wall Street analysts rate LFST "Buy" based on 10 analysts, with a mean price target of USD 11.7 (range USD 9–14), per Nexqual as of July 25, 2026 at 03:07 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 10 |
| Mean Target | USD 11.7 |
| High Target | USD 14 |
| Low Target | USD 9 |
| Buy / Hold / Sell | 9 / 2 / 0 |
Earnings (LFST)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD 0.08 |
| Revenue Estimate | $414.33M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.07 vs est 0.06 ▲ beat |
| 2025-12-31 | USD 0.09 vs est 0.05 ▲ beat |
| 2025-09-30 | USD 0.01 vs est 0.04 ▼ miss |
| 2025-06-30 | USD 0.03 vs est 0.03 ▼ miss |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
Financials & Fundamentals (LFST)
| Total Revenue | $1.49B |
|---|---|
| Revenue Growth (YoY) | +21.20% |
| Gross Margin | +32.60% |
| Operating Margin | +5.54% |
| Profit Margin | +1.55% |
| ROE | +1.58% |
| Debt / Equity | 32.27 |
| Current Ratio | 1.49 |
| Total Cash | $194.80M |
| Total Debt | $476.77M |
| Free Cash Flow | $140.70M |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
Financial Health Score (LFST)
Nexqual rates Lifestance Health Group, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:07 UTC.
| Growth | Solid — Revenue +14% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 33%, operating 6% |
| Balance Sheet | Solid — $195M cash vs $477M debt |
| Cash Flow | Solid — FCF $141M, 10% margin |
| Efficiency | Weak — ROE 2%, ROA 1.4% |
Ownership (LFST)
| Insider Ownership | +3.27% |
|---|---|
| Institutional Ownership | +89.36% |
| Shares Outstanding | 381.83M |
| Float | 238.70M |
| Short % of Float | +5.22% |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
Leadership (LFST)
Lifestance Health Group, Inc. is led by David Patrick Bourdon (age 56), CEO & Director, per Nexqual as of July 25, 2026 at 03:07 UTC.
| CEO & Director | David Patrick Bourdon (age 56) |
|---|---|
| Executive Chairman | Kenneth Alan Burdick (age 66) |
| CFO & Treasurer | Ryan Bruce McGroarty (age 52) |
| Chief Technology Officer | Vukasin Paunovich (age 53) |
| Chief Operating Officer & Principal Operating Officer | Lisa Keise Miller (age 51) |
Major Backers & Investors (LFST)
Notable institutional backers of Lifestance Health Group, Inc. include TPG GP A, LLC, FMR, LLC, Summit Partners, L.P., according to Nexqual as of July 25, 2026 at 03:07 UTC.
Active Investors
| Investor | Stake |
|---|---|
| TPG GP A, LLC | 36.1% |
| FMR, LLC | 15.13% |
| Summit Partners, L.P. | 7.53% |
| Fidelity | 6.94% |
| Jennison Associates LLC | 2.64% |
| Silversmith Partners I GP, LLC | 1.59% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.57% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.22% |
| Vanguard Group | 6.96% |
| Dimensional Fund Advisors | 2.67% |
Source: Nexqual, July 25, 2026 at 03:07 UTC.
From Lifestance Health Group, Inc.'s Latest SEC 10-K Filing (filed 2026-02-25)
Key Strengths & Strategy (as disclosed to the SEC)
- LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
- The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
- It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder.
- In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRVA | Privia Health Group, Inc. | USD 25.5 | ▲ 0.51% |
| ALHC | Alignment Healthcare, Inc. | USD 19.43 | ▼ 6.45% |
| EVCM | EverCommerce Inc. | USD 11.56 | ▲ 0.87% |
| FLYW | Flywire Corporation - Voting | USD 15.89 | ▼ 3.93% |
| SHC | Sotera Health Company | USD 17.35 | ▲ 0.35% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:07 UTC. This page is informational and not investment advice.